CN107802944A - 一种定向挤压球囊扩张导管 - Google Patents
一种定向挤压球囊扩张导管 Download PDFInfo
- Publication number
- CN107802944A CN107802944A CN201710403451.3A CN201710403451A CN107802944A CN 107802944 A CN107802944 A CN 107802944A CN 201710403451 A CN201710403451 A CN 201710403451A CN 107802944 A CN107802944 A CN 107802944A
- Authority
- CN
- China
- Prior art keywords
- sacculus
- catheter body
- dilating catheter
- outer layer
- orientation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000916 dilatatory effect Effects 0.000 title claims abstract description 38
- 230000008676 import Effects 0.000 claims abstract description 5
- 238000013461 design Methods 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 3
- 230000002457 bidirectional effect Effects 0.000 claims description 3
- 210000001595 mastoid Anatomy 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 abstract description 4
- 238000000465 moulding Methods 0.000 abstract description 3
- 239000010410 layer Substances 0.000 description 68
- 230000003902 lesion Effects 0.000 description 15
- 210000004204 blood vessel Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 4
- 238000002399 angioplasty Methods 0.000 description 4
- 230000003143 atherosclerotic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000018672 Dilatation Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 125000003473 lipid group Chemical group 0.000 description 2
- -1 polyethylene terephthalate Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100001160 nonlethal Toxicity 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000010118 platelet activation Effects 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
- A61F2/013—Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M25/0026—Multi-lumen catheters with stationary elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/104—Balloon catheters used for angioplasty
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M2025/0008—Catheters; Hollow probes having visible markings on its surface, i.e. visible to the naked eye, for any purpose, e.g. insertion depth markers, rotational markers or identification of type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M2025/0183—Rapid exchange or monorail catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
- A61M2025/1013—Multiple balloon catheters with concentrically mounted balloons, e.g. being independently inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1045—Balloon catheters with special features or adapted for special applications for treating bifurcations, e.g. balloons in y-configuration, separate balloons or special features of the catheter for treating bifurcations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1075—Balloon catheters with special features or adapted for special applications having a balloon composed of several layers, e.g. by coating or embedding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1079—Balloon catheters with special features or adapted for special applications having radio-opaque markers in the region of the balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1086—Balloon catheters with special features or adapted for special applications having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/12—Blood circulatory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
本发明属于医疗器械领域,涉及一种定向挤压球囊扩张导管。该定向挤压球囊扩张导管包括导管体和连接在导管体远端体部的双层球囊,导管体近端体部的外源输入端口连接件,球囊内设有显影环;所述双层球囊以导管体为中心,内层球囊具有高顺应性,在命名压时,预塑形为第一锥部、圆柱形工作A段、锥台形工作B段和第二锥部;外层球囊具有非顺应性,导管体包含3个独立的腔,中心腔为导丝腔,导管体的二个侧腔为内球囊连通腔、外球囊连通腔,一端分别与内、外球囊连通,另一端连接件相通。本发明定向挤压球囊扩张导管,由于内外具有不同的顺应性,内球囊的预塑形,工作时能定向扩张,能有效减少斑块体积,避免分支受累,最大限度保护内皮组织。
Description
技术领域
本发明属于医疗器械领域,涉及一种介入医疗用的球囊扩张导管,具体是一种定向挤压球囊扩张导管。
背景技术
冠状动脉粥样硬化性心脏病是当今人类主要致死、致残性疾病。经皮血管腔内球囊成形术(PTCA)/支架术是其主要的治疗方法。这种经皮冠状动脉内干预术(PCI)疗效至今仍不甚满意。首先,PCI不能真正减少死亡和非致命心肌梗死,尤其在稳定性冠心病中和优化的药物治疗方案相比较时[1,2];其次,不能长期缓解血管狭窄。6个月时单纯PTCA再狭窄率高达50%,裸金属支架再狭窄可达40%[3]。即便是采用第2代药物支架治疗,6年后较金属裸支架减少再狭窄的优势所剩无多[2]。故,PCI有需要持续改进的需求。
传统的PTCA使用半顺应或非顺应气囊进行血管病变部位扩张,管腔增大的原因为:斑块被径向压缩和管壁扩大(几乎各贡献50%[4]),伴斑块轴向移位[5]。混合性斑块或钙化斑块的管腔解剖增大的因素是斑块不规则撕裂和夹层形成[6],如图1。这种扩张的后果是,破坏了病变原有完整性,斑块沿血管轴向迁移,不但容易引起边支受累,还使得致炎的脂质核成分影响范围被人为扩大,血管内膜受损,中膜断裂外膜张力性膨出,进而促发机体的增生修复反应。因此,在获得解剖意义上的管腔增加时,换来的是,血管机械性创伤,炎症扩散,斑块破裂移位。
组织学研究表明,因内皮受损、管壁物质的趋化作用,在PCI术后早期血管扩张区域即出现血小板激活、黏附,及附壁血栓形成;同时血管内膜出现大量的巨噬细胞和幼稚的平滑肌细胞浸润,这些细胞及其间质是新生内膜的主要构成成分[7],正是这种过度增生的新生内膜导致了血管再狭窄。
由此可见,传统的血管内球囊成形术一方面没有真正减少动脉粥样硬化斑块体积,尤其是没有减少致炎的成分,另一方面,却导致了管壁炎症激活、扩展以及内膜完整性破坏,这是传统PCI获益受限的主要原因。如何减少粥样斑块的脂核负荷(致炎的主要成分),并最大程度保护内皮层,是亟待解决的问题。
专利CN1010 45175A、CN103623497A和CN104857615A都公开了一种双层球囊,但所涉及的双层球囊,其使用目的仅仅是解决提供局部给药的路径和方法;不能解决粥样斑块的脂核负荷问题。
专利CN201394274Y和CN204395193所涉及双层球囊是为了解决单层球囊可能破裂的问题,内外层球囊材质、形状一致;不能解决粥样斑块的脂核负荷问题并保护内皮层。
专利CN201135683[P]和CN105662668A提供的是一种单层锥形球囊,用于管径落差大的血管节段的病变扩张并改善通过性,但仍不能解决粥样斑块的脂核负荷问题并保护内皮层。
本发明受启发于临床脓肿的治疗方法。化脓性疾病一个显著特点是中央有个强致炎的囊性包裹区,外周是炎症细胞包绕的多层结构。脓肿最有效的治疗方法是切开引流,只有引流出脓肿核心方可痊愈。动脉粥样硬化性病灶与之类似,推测必须切开病灶并排掉脂质核物质,减少致炎作用,才可从根本上改善动脉粥样硬化性病变的预后。
既往有定向斑块旋切或旋磨技术,用于斑块减容术,这个技术被证明并不优于传统的PCI,可能与其造成血管损伤范围过大,内膜损伤过于严重有关。而内皮具有抗增生、抗血栓、促进损伤愈合作用[8],故本发明提供的技术关键优势在于,在去除脂质核等病理组织同时最大程度保护了内皮组织。
参考文献
[1]Boden WE,O'Rourke RA,Teo KK,et al;COURAGE Trial ResearchGroup.Optimal medical therapy with or without PCI for stable coronarydisease.N Engl J Med.2007;356(15):1503-16.
[2]KH,Mannsverk J,Wiseth R,et al;NORSTENT Investigators.Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease.N Engl J Med.2016;375(13):1242-52.
[3]Buccheri D,Piraino D,Andolina G,et al.Understanding and managingin-stent restenosis:a review of clinical data,from pathogenesis totreatment.J Thorac Dis.2016;8(10):E1150-62.
[4]Baptista J,Umans VA,di Mario C,et al.Mechanisms of luminalenlargement and quantification of vessel wall trauma following ballooncoronary angioplasty and directional atherectomy.Eur Heart J.1995;16(11):1603-12.
[5]Mintz GS,Pichard AD,Kent KM,et al.Axial plaque redistribution as amechanism of percutaneous transluminal coronary angioplasty.Am JCardiol.1996;77(5):427-30.
[6]Ahmed JM1,Mintz GS,Weissman NJ,et al.Mechanism of lumenenlargement during intracoronary stent implantation:an intravascularultrasound study.Circulation.2000;102(1):7-10.
[7]Komatsu R,Ueda M,Naruko T,et al.Neointimal tissue response atsites of coronary stenting in humans:macroscopic,histological,andimmunohistochemical analyses.Circulation.1998;98(3):224-33.
[8]Noma K,Kihara Y,Higashi Y.Outstanding Effect of Physical Exerciseon Endothelial Function Even in Children and Adolescents.Circ J.2017;81(5):637-639.
发明内容
为了解决粥样斑块的脂核负荷,并最大程度保护内皮层,本发明提供一种定向挤压球囊旨在通过球囊的定向扩张减少斑块体积,避免分支受累,最大限度保护内皮组织。
本发明解决上述问题所采取的技术方案是:
一种定向挤压球囊扩张导管,一种定向挤压球囊扩张导管,包括导管体和连接在导管体远端体部的双层球囊,导管体近端体部设有外源输入端口连接件,球囊内设有显影环;所述双层球囊以导管体为中心,为同轴相套设计;双层球囊的内层和外层的两端部分别与导管体密封连接;内层球囊具有高顺应性,在初始工作状态也即命名压时,预塑形为第一锥部、圆柱形工作A段、圆台形工作B段和第二锥部;外层球囊具有非顺应性;导管体包含3个独立的腔,中心腔为导丝腔,导管体的二个侧腔为内球囊连通腔、外球囊连通腔,所述内球囊连通腔与外球囊连通腔的一端与连接件相通,另一端通过进出孔分别与内层球囊和外层球囊相通;外球囊连通腔上的进出孔设置于内层球囊和外层球囊之间;内球囊连通腔上的进出孔设置于内层球囊内。
本发明的关键在于定向挤压球囊的设计,对于导管系统没有限制,可以是快速交换球囊导管或同轴交换球囊导管。如本领域技术人员所知晓的,如果导丝出口在球囊扩张导管中间段(连接件与球囊之间的导管体体部),称为快速交换球囊导管;如果导丝出口在连接件的端,称为同轴交换球囊导管(on-the-wire)。
本发明中,导丝腔一端与导丝管相连,另一端开口于导丝出口,所述导丝出口位于连接件与球囊之间的导管体体部或者位于外源输入端口连接件。
当采用快速交换球囊导管形式时,所述连接件具有两个独立端口,分别为内、外球囊连通腔的连接口;两个连接口分别设置有双向旋转开关。当采用同轴交换球囊导管形式时,所述连接件可以具有3个独立端口,分别与导管体的3个腔连通。
本发明中,外层球囊具有非顺应性,其工作段形状为常规的,例如可根据血管管径的特点设计为圆柱形或圆台形(图3)结构,其加压充盈时包括第一锥部、圆柱形工作A段和圆柱形或圆台形B段、第二锥部。由于其非顺应性,在形状上构成对内层球囊膨胀的限制。外层球囊的圆柱形工作A段和B段位置对应于内层球囊的圆柱形工作A段和锥台形工作B段。
本发明中,内层球囊具有顺应性,其工作段预塑形为圆柱A段+圆台B段。工作时,圆柱A段的作用主要是固定;圆台B段的主要作用是在加压膨胀直至被外层球囊限制过程中对血管壁产生定向挤压。可以理解,在初始工作状态时,内外层的圆柱A段即达到相同,而内层球囊工作B段在初始工作状态时的预塑形体积应当小于外层球囊工作B段体积。优选地,在初始工作状态也即命名压时,内层球囊预塑形的圆台形工作B段与第二锥部一同形成圆锥形。
本发明中,所述双层球囊在导管体上的方向是可选的,第一锥部朝向连接件方向,或者是第二锥部朝向连接件方向。
本发明所述的定向挤压球囊扩张导管,所述外球囊连通腔上的进出孔为2-4个;所述内球囊连通腔上的进出孔为2-6个。
本发明中,所述显影环优选为两个,分别位于工作段两端相应位置,所述工作段是指工作A段加工作B段。以辅助定位。
对于本发明的定向挤压球囊扩张导管来说,为了便于固定,可采用以下方式:一种是在所述双层球囊的远端连接有固定球囊。另一种是在外层球囊的圆柱形工作A段区域设有向外突出的固定结构;进一步地,所述的固定结构为乳突状,在外层球囊上呈对称分布。
本发明的定向挤压球囊扩张导管,还可在外层球囊壁上设置1um-100um微孔,成孔率5-90%。内层球囊膨胀时可以经外层球囊腔输送药物,通过微孔作用于管壁。
本发明的定向挤压球囊扩张导管,可在其外层球囊表面装载药物。
球囊的顺应性,指球囊的直径随球囊充盈压力变化的程度。公式表示:
球囊的顺应性=球囊额度压力下的直径/球囊命名压下的直径
球囊的顺应性为1.05-1.10时,称为非顺应性球囊;顺应性为1.18-1.30时,称为半顺应性球囊;顺应性超过1.30,为顺应性球囊,其体积变化范围在100-600%。
本发明中的双层球囊,其内、外层由不同顺应性材质制成,内层为高顺应性材质,并经过预塑形,工作段为圆柱+圆台形,外层为非顺应材质制成的传统球囊。内层球囊连续加压时,因为内层球囊的高顺应性,内层球囊轴向扩张,外层球囊被动扩张,结果球囊对斑块产生轴向挤压效应。此外,内层球囊在持续充盈过程中,内层球囊壁相对外层球囊壁滑动,而外层球囊相对斑块位移少,故外层球囊和血管内膜摩擦力小,如此,和传统球囊相比,本案球囊在扩张过程中对内膜损害较小。
本发明所述的球囊扩张导管,其中,优选地,所述球囊体扩张后的直径为1.0-20.0mm,长度为5mm—100mm。球囊体的工作压力为2-30个标准大气压。导丝腔的内径为0.1mm-1.5mm。
所述球囊的材质为医用高分子材料,可选为:交联聚乙烯和聚苯二甲酸乙二醇酯、聚四氟乙烯、尼龙、聚氨酯或其他材料的合金。
球囊使用前,球囊抽瘪双层紧密贴合并折叠。使用时,球囊整体跨越病变,逐渐增加内层球囊压力并达到命名压时,内层球囊与外层球囊的第一锥部和工作A段同步膨胀,大小和形状等同命名的大小和形状。继续加压内层球囊,内、外层球囊工作B段逐渐膨胀,形成锥形方向上对血管壁连续施压,如此球囊对血管斑块产生轴向定向挤压作用,如图2所示;因为外层球囊具有非顺应性,对内层球囊的大小、形状起限制作用。本发明球囊和远端保护装置、切割球囊及支架等配合使用,达到扩张管腔,减少斑块容积效果。此外,主动充盈外层球囊可以行更高压力扩张,包括支架后扩张。
该球囊使用时的第一锥部至第二锥部的方向与血管近远端方向一致时,称为正向定向扩张球囊;该球囊使用时的第一锥部至第二锥部的方向与血管近远端方向相反时,称为反向定向扩张球囊。
本发明中所述的球囊可装载相应支架,并进行所述支架释放操作。
本发明与现有技术相比,具有以下有益效果:
1)与切割球囊、远端保护装置配合使用时,通过挤压发挥斑块减容效应,这种作用改变了传统的血管腔内球囊成形术(PTCA)/支架术的机制。
2)处理分叉病变时,定向推移和减容斑块,不易影响分支。
3)当仅充盈内层球囊时不能够充分扩张病变或支架时,可以直接加压外层非顺应球囊,直至达到目标。
4)还发挥药物球囊的作用:
(1)外层球囊表面装载药物,在球囊膨胀后与血管壁紧密贴合,将药物释放至管壁;
(2)当外层球囊设计为带微孔膜时,在内层球囊膨胀后,外层球囊紧密贴靠血管壁,可以经外层球囊腔给药,施于血管壁局部。
附图说明
图1是传统的球囊成形术示意图。
图2是本发明定向挤压球囊的结构和工作示意图;A.命名压工作状态,B.内层球囊加压过程中,C.加压至完全膨胀状态。
图3外层球囊工作B段为圆台形的扩张导管。
图4是球囊扩张导管近中段结构图。
图5是球囊扩张导管结构图。A:正向定向球囊,B:反向定向球囊
图6带有乳突状结构的定向球囊扩张导管。
图7远端带有固定球囊的定向球囊扩张导管。
图8球囊扩张导管工作示意图。
图9是球囊扩张导管用于治疗分叉病变(Medina010或001)示意图。
图10是球囊扩张导管用于治疗分叉病变(Medina100)示意图。
具体实施方式
实施例1
图5是球囊扩张导管结构图。定向挤压球囊扩张导管,包括同轴相连的导丝管7、导管体8和连接在导管体远端体部的双层球囊9,导管体近端体部设有外源输入端口连接件,球囊内设有显影环10。双层球囊9在导管体上可以设计为不同方向,A:正向定向球囊,B:反向定向球囊。做为一个实例,该球囊扩张导管的尺寸可以是:L1:120-250cm,L2:15-100cm,L3:0.5—5.0cm,d:1.25mm—8.0mm,d1:0.6—1.5mm。
如图2A,所述双层球囊9以导丝腔为中心,为同轴相套设计;双层球囊的内层和外层的两端部分别与导管体密封连接;内层球囊具有高顺应性,预塑形为第一锥部、圆柱形工作A段、锥台形工作B段和第二锥部;外层球囊具有非顺应性,有与内层球囊同样大小、形状的第一锥部和圆柱形工作A段,圆台形工作B段。图2显示了A.命名压工作状态,B.内层球囊加压过程中,C.加压至完全膨胀状态。
本实施例采用的导管为快速球囊交换导管,如图4,导管体包含3个独立的腔,中心腔为导丝腔6,导丝腔6一端与导丝管相连,另一端开口于连接件与球囊之间的导管体体部的导丝出口5;导管体的二个侧腔为内球囊连通腔3、外球囊连通腔4,所述内球囊连通腔3与外球囊连通腔4的一端与连接件相通,另一端通过进出孔分别与内层球囊和外层球囊相通;外球囊连通腔4上的进出孔设置于内层球囊和外层球囊之间;内球囊连通腔3上的进出孔设置于内层球囊内;连接件具有两个独立端口,分别为内球囊连通腔的连接口1和外球囊连通腔的连接口1;两个连接口上分别设置有双向旋转开关。
图6是另一种固定方式,是在外层球囊的圆柱形工作A段区域设有向外突出的固定结构11。
图7是本发明球囊扩张导管的一种固定方式,双层球囊9的远端连接有固定球囊12。
实施例2
举例说明本发明球囊导管使用的3种情况
1、一个动脉粥样硬化病灶的减容治疗方法,如图8:
1)在常规的介入操作基础上,于病变远端安置一个可回收的远端保护装置13
2)使用切割球囊切割斑块
3)再使用本发明提供的定向挤压气囊9,将斑块组织的内部成分定向挤出斑块
4)如需更高压力扩张,主动充盈外层球囊至更高压力
5)或使用本发明提供的定向挤压气囊所装载的支架,在挤出斑块组织的同时给予支架成形术
6)回收远端保护装置,将斑块挤出的成分取出体外。
2、分叉病变(Medina010或001)的处理
使用本发明提供球囊施行定向挤压球囊扩张成形术,自病变向远端定向挤压斑块,使不影响分支开口,如图9。
步骤1:定向挤压球囊9到位,其远端有远端保护装置13,以命名压开始扩张;
步骤2:定向挤压球囊9持续加压至目标充盈压;
步骤3:定向挤压球囊9撤出后,挤压物被远端保护装置13收集。
3、分叉病变(Medina100)的处理
使用本发明提供球囊施行定向挤压球囊扩张成形术,自病变的远端朝着近端定向挤压斑块,使不影响分支开口,如图10。
步骤1:切割球囊切割斑块表面后,反向定向挤压球囊9扩张(分支血管内置球囊14并膨胀,防止斑块挤出物进入分支血管);
步骤2:定向挤压球囊导管撤出(分支血管内球囊保持膨胀,斑块挤出物被置于主支血管远端的保护装置13收集);
步骤3:撤出血管内装置,根据定向球囊扩张后的血管情况,决定置入或不置入支架。
Claims (10)
1.一种定向挤压球囊扩张导管,包括导管体和连接在导管体远端体部的双层球囊,导管体近端体部设有外源输入端口连接件,球囊内设有显影环;其特征在于,所述双层球囊以导管体为中心,为同轴相套设计;双层球囊的内层和外层的两端部分别与导管体密封连接;内层球囊具有高顺应性,在命名压时,预塑形为第一锥部、圆柱形工作A段、圆台形工作B段和第二锥部;外层球囊具有非顺应性;导管体包含3个独立的腔,中心腔为导丝腔,导管体的二个侧腔为内球囊连通腔、外球囊连通腔,所述内球囊连通腔与外球囊连通腔的一端与连接件相通,另一端通过进出孔分别与内层球囊和外层球囊相通;外球囊连通腔上的进出孔设置于内层球囊和外层球囊之间;内球囊连通腔上的进出孔设置于内层球囊内。
2.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,所述扩张导管是快速交换球囊导管或同轴交换球囊导管。
3.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,所述连接件具有两个独立端口,分别为内、外球囊连通腔的连接口;两个连接口分别设置有双向旋转开关。
4.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,所述双层球囊在导管体上的方向是可选的,第一锥部朝向连接件方向,或者是第二锥部朝向连接件方向。
5.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,所述外球囊连通腔上的进出孔为2-4个;所述内球囊连通腔上的进出孔为2-6个。
6.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,所述显影环为两个,分别位于工作段两端相应位置,所述工作段是指工作A段加工作B段。
7.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,所述双层球囊的远端连接有固定球囊和/或在外层球囊的圆柱形工作A段区域设有向外突出的固定结构。
8.根据权利要求7所述的定向挤压球囊扩张导管,其特征在于,所述的固定结构为乳突状,在外层球囊上呈对称分布。
9.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,外层球囊壁上设置1um-100um微孔,成孔率5-90%。
10.根据权利要求1所述的定向挤压球囊扩张导管,其特征在于,外层球囊表面装载药物。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710403451.3A CN107802944A (zh) | 2017-06-01 | 2017-06-01 | 一种定向挤压球囊扩张导管 |
PCT/CN2017/094640 WO2018218781A1 (zh) | 2017-06-01 | 2017-07-27 | 一种定向挤压球囊扩张导管 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710403451.3A CN107802944A (zh) | 2017-06-01 | 2017-06-01 | 一种定向挤压球囊扩张导管 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107802944A true CN107802944A (zh) | 2018-03-16 |
Family
ID=61576445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710403451.3A Pending CN107802944A (zh) | 2017-06-01 | 2017-06-01 | 一种定向挤压球囊扩张导管 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107802944A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112439121A (zh) * | 2019-08-27 | 2021-03-05 | 乐普(北京)医疗器械股份有限公司 | 一种非顺应性pta球囊扩张导管 |
CN114681765A (zh) * | 2020-12-30 | 2022-07-01 | 上海微创心通医疗科技有限公司 | 扩张球囊及球囊扩张导管 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5447497A (en) * | 1992-08-06 | 1995-09-05 | Scimed Life Systems, Inc | Balloon catheter having nonlinear compliance curve and method of using |
US20030078538A1 (en) * | 2000-12-28 | 2003-04-24 | Neale Paul V. | Inflation device for dual balloon catheter |
US6592568B2 (en) * | 2001-01-11 | 2003-07-15 | Scimed Life Systems, Inc. | Balloon assembly for stent delivery catheter |
CN2925510Y (zh) * | 2006-07-13 | 2007-07-25 | 上海交通大学医学院附属新华医院 | 一种术中用的幽门扩张器 |
CN103987421A (zh) * | 2011-10-06 | 2014-08-13 | W.L.戈尔及同仁股份有限公司 | 用于组织治疗的孔隙率可控的装置、使用方法和制造方法 |
CN207928567U (zh) * | 2017-06-01 | 2018-10-02 | 刘逸 | 一种定向挤压球囊扩张导管 |
-
2017
- 2017-06-01 CN CN201710403451.3A patent/CN107802944A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5447497A (en) * | 1992-08-06 | 1995-09-05 | Scimed Life Systems, Inc | Balloon catheter having nonlinear compliance curve and method of using |
US20030078538A1 (en) * | 2000-12-28 | 2003-04-24 | Neale Paul V. | Inflation device for dual balloon catheter |
US6592568B2 (en) * | 2001-01-11 | 2003-07-15 | Scimed Life Systems, Inc. | Balloon assembly for stent delivery catheter |
CN2925510Y (zh) * | 2006-07-13 | 2007-07-25 | 上海交通大学医学院附属新华医院 | 一种术中用的幽门扩张器 |
CN103987421A (zh) * | 2011-10-06 | 2014-08-13 | W.L.戈尔及同仁股份有限公司 | 用于组织治疗的孔隙率可控的装置、使用方法和制造方法 |
CN207928567U (zh) * | 2017-06-01 | 2018-10-02 | 刘逸 | 一种定向挤压球囊扩张导管 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112439121A (zh) * | 2019-08-27 | 2021-03-05 | 乐普(北京)医疗器械股份有限公司 | 一种非顺应性pta球囊扩张导管 |
CN114681765A (zh) * | 2020-12-30 | 2022-07-01 | 上海微创心通医疗科技有限公司 | 扩张球囊及球囊扩张导管 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10124153B2 (en) | Balloon catheter and methods of use thereof | |
CN207928567U (zh) | 一种定向挤压球囊扩张导管 | |
US8262611B2 (en) | Occlusion perfusion catheter | |
CN104039370B (zh) | 洗脱医疗装置 | |
CN107308536A (zh) | 包括药物输送护套的球囊导管 | |
US20230347117A1 (en) | Medical balloon having a plurality of structural layers | |
US20040210191A1 (en) | Drug delivery balloon catheter | |
CN101827567A (zh) | 具有内部药物递送系统的医疗植入物 | |
US20100261662A1 (en) | Utilization of mural thrombus for local drug delivery into vascular tissue | |
EP0781149A1 (en) | Catheter sleeve and method of use | |
US10806908B2 (en) | Balloon catheter | |
US20050075710A1 (en) | Balloonless direct stenting device | |
US20090155337A1 (en) | Method and agent for in-situ stabilization of vascular tissue | |
US8292942B2 (en) | Double-balloon delivery system for an implantable eccentric stent | |
CN107802944A (zh) | 一种定向挤压球囊扩张导管 | |
CN108355230A (zh) | 多导丝药物球囊扩张导管及其使用方法 | |
CN104105525A (zh) | 球囊导管系统 | |
WO2018008514A1 (ja) | バルーンカテーテル | |
CN109731206B (zh) | 一种用于生物体内管路分叉病变的球囊及其用途 | |
CN208911235U (zh) | 多导丝药物球囊扩张导管 | |
JP6771970B2 (ja) | バルーンカテーテル | |
WO2018008516A1 (ja) | バルーンカテーテル | |
CN202191581U (zh) | 多层球囊扩张导管 | |
CN105726175B (zh) | 一种用于分叉病变介入治疗的特型主支球囊支架系统 | |
WO2018218781A1 (zh) | 一种定向挤压球囊扩张导管 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180316 |